609O CLDN18.2 targeted antibody-drug conjugate (ADC), SHR-A1904, in patients (pts) with gastric/gastroesophageal junction cancer (GC/GEJC): A phase I study

作者：R-H. Xu, Dan Ruan, Song Luo, X. Liang, Zuoxing Niu, Qiang Dang, Zhizhong Pan, Ying Zhang, X. Li, Hengyuan Li, Xin Xiao, Sanjun Cai, Yizhou Dong, Jiyong Zhang, Z. Li, Hui Lan, Hui Lü, S. Wang, Qing Wu, Jian‐Wei Xie · 发表于：Annals of Oncology · 年份：2024 · DOI：10.1016/j.annonc.2024.08.676 · 被引用次数：10 · 研究领域：Gastric Cancer Management and Outcomes、Colorectal Cancer Treatments and Studies、Gastrointestinal Tumor Research and Treatment